Christopher Scally, M.D., M.S., is an Assistant Professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center. His clinical practice focuses on the care of patients with advanced gastrointestinal malignancies and soft-tissue sarcomas. He has particular interest in the treatment of peritoneal surface malignancies, and offers cytoreductive surgery with heated intraperitoneal chemotherapy (HIPEC) to appropriate patients. Dr. Scally received his undergraduate degree from the University of Notre Dame and his medical degree from Vanderbilt University School of Medicine. He completed his General Surgery training at the University of Michigan, followed by a fellowship in Complex General Surgical Oncology at the University of Texas MD Anderson Cancer Center. He also holds a Masters Degree in Healthcare Research from the University of Michigan, where he was a fellow in the Center for Healthcare Outcomes and Policy.